Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • ACEI/ARB therapy in COVID-19:...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking

ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking

Bibliographic Details
Main Authors: Chidinma L. Onweni, Yu Shrike Zhang, Thomas Caulfield, Christopher E. Hopkins, De Lisa Fairweather, William D. Freeman
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Critical Care
Subjects:
ACE2
ACEI/ARB therapy
COVID-19
Online Access:http://link.springer.com/article/10.1186/s13054-020-03195-9
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://link.springer.com/article/10.1186/s13054-020-03195-9

Similar Items

  • ACEIs and ARBs and Their Correlation with COVID-19: A Review
    by: Yehualashet AS, et al.
    Published: (2020-09-01)
  • Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
    by: Gian Paolo Rossi, et al.
    Published: (2020-04-01)
  • COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients
    by: Sieńko J, et al.
    Published: (2020-07-01)
  • Antihypertensive Therapy by ACEI/ARB Is Associated With Intestinal Flora Alterations and Metabolomic Profiles in Hypertensive Patients
    by: Ying Dong, et al.
    Published: (2022-03-01)
  • Efficacy and safety of tripterygium glycosides combined with ACEI/ARB on diabetic nephropathy: a meta-analysis
    by: Zhuan’E. Yao, et al.
    Published: (2025-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs